GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » Cash, Cash Equivalents, Marketable Securities

Zhaoke Ophthalmology (HKSE:06622) Cash, Cash Equivalents, Marketable Securities : HK$1,271.77 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology Cash, Cash Equivalents, Marketable Securities?

Zhaoke Ophthalmology's quarterly cash, cash equivalents, marketable securities declined from Dec. 2023 (HK$1,598.69 Mil) to Jun. 2024 (HK$1,514.09 Mil) but then stayed the same from Jun. 2024 (HK$1,514.09 Mil) to Dec. 2024 (HK$1,271.77 Mil).

Zhaoke Ophthalmology's annual cash, cash equivalents, marketable securities declined from Dec. 2022 (HK$1,926.58 Mil) to Dec. 2023 (HK$1,598.69 Mil) and declined from Dec. 2023 (HK$1,598.69 Mil) to Dec. 2024 (HK$1,271.77 Mil).


Zhaoke Ophthalmology Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Zhaoke Ophthalmology's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology Cash, Cash Equivalents, Marketable Securities Chart

Zhaoke Ophthalmology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 1,032.92 2,616.18 1,926.58 1,598.69 1,271.77

Zhaoke Ophthalmology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 1,926.58 1,831.79 1,598.69 1,514.09 1,271.77

Zhaoke Ophthalmology Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Zhaoke Ophthalmology  (HKSE:06622) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Zhaoke Ophthalmology Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhaoke Ophthalmology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » Cash, Cash Equivalents, Marketable Securities
Traded in Other Exchanges
Address
No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN
Zhaoke Ophthalmology Ltd is a ophthalmic pharmaceutical company dedicated to the research, development, manufacture and commercialization of therapies that address significant unmet medical needs. The company has three flagship drug assets processing towards potential market approval NVK002 for myopia, CsA Ophthalmic Gel for DED and TAB014 for wAMD; and two promising drug assets in the clinical stage BRIMOCHOL PF for presbyopia and ZKY001 for corneal epithelial defects. Geographically the company operates in Hong Kong, Mainland China, South Korea, and Others.
Executives
Mak Siu Hang Viola 2201 Interest of corporation controlled by you
Gic Private Limited 2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd 2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd 2101 Beneficial owner
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Fidelity China Special Situations Plc 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Vms Holdings Limited 2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p. 2201 Interest of corporation controlled by you

Zhaoke Ophthalmology Headlines

No Headlines